|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fidler IJ: The pathogenesis of cancer
metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee YT: Breast carcinoma: Pattern of
metastasis at autopsy. J Surg Oncol. 23:175–180. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baek D, Villén J, Shin C, Camargo FD, Gygi
SP and Bartel DP: The impact of microRNAs on protein output.
Nature. 455:64–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
van Rooij E, Marshall WS and Olson EN:
Toward microRNA-based therapeutics for heart disease: The sense in
antisense. Circ Res. 103:919–928. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma L, Reinhardt F, Pan E, Soutschek J,
Bhat B, Marcusson EG, Teruya-Feldstein J, Bell GW and Weinberg RA:
Therapeutic silencing of miR-10b inhibits metastasis in a mouse
mammary tumor model. Nat Biotechnol. 28:341–347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li LJ, Huang Q, Zhang N, Wang GB and Liu
YH: miR-376b-5p regulates angiogenesis in cerebral ischemia. Mol
Med Rep. 10:527–535. 2014.PubMed/NCBI
|
|
10
|
Pan Z, Guo Y, Qi H, Fan K, Wang S, Zhao H,
Fan Y, Xie J, Guo F, Hou Y, et al: M3 subtype of muscarinic
acetylcholine receptor promotes cardioprotection via the
suppression of miR-376b-5p. PLoS One. 7:e325712012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dai L, Cui X, Zhang X, Cheng L, Liu Y,
Yang Y, Fan P, Wang Q, Lin Y, Zhang J, et al: SARI inhibits
angiogenesis and tumour growth of human colon cancer through
directly targeting ceruloplasmin. Nat Commun. 7:119962016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cronin PA, Wang JH and Redmond HP: Hypoxia
increases the metastatic ability of breast cancer cells via
upregulation of CXCR4. BMC Cancer. 10:2252010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Myers C, Charboneau A, Cheung I, Hanks D
and Boudreau N: Sustained expression of homeobox D10 inhibits
angiogenesis. Am J Pathol. 161:2099–2109. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sekar P, Bharti JN, Nigam JS, Sharma A and
Soni PB: Evaluation of p53, HoxD10 and E-Cadherin status in breast
cancer and correlation with histological grade and other prognostic
factors. J Oncol. 2014:7025272014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hakami F, Darda L, Stafford P, Woll P,
Lambert DW and Hunter KD: The roles of HOXD10 in the development
and progression of head and neck squamous cell carcinoma (HNSCC).
Br J Cancer. 111:807–816. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Q, Ding C, Chen C, Zhang Z, Xiao H, Xie
F, Lei L, Chen Y, Mao B, Jiang M, et al: miR-224 promotion of cell
migration and invasion by targeting Homeobox D 10 gene in human
hepatocellular carcinoma. J Gastroenterol Hepatol. 29:835–842.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu Z, Zhu J, Cao H, Ren H and Fang X:
miR-10b promotes cell invasion through RhoC-AKT signaling pathway
by targeting HOXD10 in gastric cancer. Int J Oncol. 40:1553–1560.
2012.PubMed/NCBI
|
|
18
|
Vardhini NV, Rao PJ, Murthy PB and
Sudhakar G: HOXD10 expression in human breast cancer. Tumour Biol.
35:10855–10860. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiao H, Li H, Yu G, Xiao W, Hu J, Tang K,
Zeng J, He W, Zeng G, Ye Z and Xu H: MicroRNA-10b promotes
migration and invasion through KLF4 and HOXD10 in human bladder
cancer. Oncol Rep. 31:1832–1838. 2014.PubMed/NCBI
|
|
20
|
Pulaski BA, Terman DS, Khan S, Muller E
and Ostrand-Rosenberg S: Cooperativity of staphylococcal aureus
enterotoxin B superantigen, major histocompatibility complex class
II, and CD80 for immunotherapy of advanced spontaneous metastases
in a clinically relevant postoperative mouse breast cancer model.
Cancer Res. 60:2710–2715. 2000.PubMed/NCBI
|
